Ronald J. Friedman


Ronald J. Friedman

1024 453 Karr Tuttle Campbell

Ron Friedman’s practice focuses on regulatory and healthcare compliance, white collar criminal defense, pharmacy law, and complex litigation. Ron is dedicated to helping people and businesses safely and successfully navigate difficult and challenging problems. Ron listens to his clients and works innovatively and amicably to identify the best path forward. Mr. Friedman entered private practice after a distinguished career with the United States Department of Justice, having served 22 years as a federal prosecutor in Seattle.

Ron Friedman’s practice focuses on regulatory and healthcare compliance, white collar criminal defense,  complex litigation, and professional license defense. Ron entered private practice after a distinguished career with the United States Department of Justice, serving 22 years as a federal prosecutor in Seattle where he gained exposure to a variety of legal issues. Ron prosecuted hundreds of cases, supervised federal grand juries for 6 years, and successfully tried many cases. Ron is responsible for developing multiple highly successful and nationally recognized law enforcement programs, including Operation Stolen Valor focusing on armed services fraud, and Operation Midnight Express focusing on drug diversion.


Ron’s private practice is very diverse and he enjoys helping people navigate difficult and challenging problems. He handles a variety of complex regulatory, civil, and criminal matters on behalf of individuals and businesses. Ron regularly assists clients with compliance issues, and advises and defends clients facing government investigations of all types, civil and criminal.  Ron represents individuals and companies in a variety of contexts, including clients who are the target or subject of regulatory investigations, clients wishing to implement compliance and due diligence protocols, clients who are witnesses in grand jury proceedings, and clients accused of criminal wrongdoing at all stages of proceedings.  In criminal matters, Ron has helped many clients successfully avoid charges and fines entirely, reduced their exposure, or obtained dismissal of charges.  While the results achieved in any case may vary, persistence, reasonableness, and commitment to principle have been key to this success.


Ron has extensive experience in healthcare and pharmaceutical compliance and licensing. Ron represents many companies at all levels of the healthcare and pharmaceutical distribution chain, as well as food and medical device manufacturers and distributors.  In addition, Ron assists healthcare providers and practitioners with successful resolution of regulatory issues, including disciplinary proceedings. In addition, Ron has substantial experience defending civil qui tam and false claims actions, and responding to financial fraud and business practice issues and investigations.

  • Best Lawyers in America®, White Collar Criminal Defense, 2011-2019
  • “Washington Super Lawyer,” Super Lawyers Magazine®, White Collar Criminal Defense, 2013-2014, 2017-2020
  • Director’s Award, United States Attorney General—for excellence in a case involving foreign corporations conducting unauthorized business in the U.S. in violation of U.S. law.
  • Represented national drug manufacturer in civil action by state Attorney General alleging negligence, public nuisance, violations of state consumer protection act.
  • Represented the president of a hospital services corporation in federal criminal case alleging securities fraud and market manipulation
  • Represented national retail drug chain in DEA compliance investigation
  • Represented national drug wholesaler in board of pharmacy compliance investigation
  • Represented a major league sports franchise in DEA regulatory investigation; no charges brought
  • Represented pharmacist in dispute with Kansas Board of Pharmacy challenging an order revoking the license of the pharmacist.  The order was vacated in its entirety and dismissed.
  • Represented the president of an environmental inspection company in federal criminal case alleging conspiracy to defraud and violations of Clean Air Act; all felony charges dismissed
  • Represented local compounding pharmacy in Florida Board of Pharmacy investigation resulting from FDA inspection.  No charges brought.
  • Represented national drug distributor in Board of Pharmacy compliance proceedings
  • Represented specialty pharmacy in PBM dispute. Complete recovery made
  • Represented clinic-based pharmacy in FDA compliance investigation. Successfully resolved
  • Represented compounding pharmacy in FDA compliance investigation. Successfully resolved
  • Represented national drug manufacturer in federal civil action relating to alleged false claims
  • Represented national pharmacy retail chain in DEA compliance investigation
  • Represented corporate employee in “insider trading” investigation; no charges brought following federal investigation
  • Represented a retail drug store chain and pharmacists in DEA and state regulatory investigation alleging noncompliance and records violations
  • Represented a national food manufacturer in FDA action seeking a recall; recall averted
  • Represented mega-church in federal criminal investigation; no charges brought
  • Represented an aircraft parts supplier in due diligence FCPA investigation
  • Represented national engineering firm in Qui Tam civil fraud investigation; fraud charges dismissed
  • Represented CFO of a national labor corporation in whistleblower investigation alleging accounting fraud
  • Represented CFO of a national engineering company in Department of Defense fraud investigation; no charges brought
  • Represented national drug distributor in DEA criminal investigation related to 21 CFR compliance. No charges brought.
  • Represented closed door hospice and specialty pharmacies with variety of business, regulatory, and licensing issues
  • Represented several out of state pharmacies, including compounding and specialty pharmacies in regulatory board of pharmacy proceedings in their states
  • Represented numerous physicians in responding to Medical Quality Assurance Commission investigations and developing due diligence protocols
  • Represented medical trauma training center in DEA regulatory compliance investigation
  • Represented physician in criminal investigation alleging unlawful inducement/kickbacks. No charges brought
  • Represented physician in criminal investigation alleging unlawful distribution of a controlled
  • substance. No charges brought.
  • Represented multiple pain clinics and physicians in DEA and state board compliance investigations across the United States
  • Represented CEO of an oil drilling company conducting business overseas in a criminal case alleging wire fraud and tax evasion
  • Represented a chain of health care clinics and a corporate officer in an FDA investigation alleging unlawful importation of a misbranded drug, sale of an unapproved new drug and false statements
  • Represented a national medical product wholesaler in an FDA investigation alleging misbranding and improper sale of merchandise. Recall averted; product deemed compliant
  • Represented a national environmental company in an investigation alleging violations of the Clean Water Act, RCRA and FIFRA; no charges brought following federal investigation
  • Represented a Washington State political party official in a federal criminal investigation alleging fraud and false statement; federal indictment dismissed
  • Represented a national drug wholesaler and distributor in an FDA criminal investigation alleging the sale of stolen merchandise; no charges brought following lengthy DOJ investigation
  • Represented a financial investment advisor in a federal criminal case alleging bank fraud, breach of fiduciary duty, and unlawful conversion; no charges brought
  • Represented a public school fiscal officer in an investigation alleging theft and public corruption; no charges brought
  • Represented a seafood processing company in a State investigation alleging criminal violations of fisheries law
  • Represented a media representative in an FBI investigation alleging unauthorized disclosure of classified information
  • Represented pharmacies, pharmaceutical, and health care companies in licensing matters and regulatory compliance
  • “New Objects of Addiction,” American Conference Institute’s Third National Summit on Controlled Substances (July 22, 2020)
  • Regulatory Compliance Involving Ekits and Navigating the Theft/Loss Reporting Requirement In The Long Term Care Sector”, American Society of Pharmacy Law Annual Conference (November 8, 2019)
  • “Pharmacy Law Regulatory Update:  Red Flags, Suspicious Orders, and PDMP Programs,” National Association of Specialty Pharmacy (NASP), Annual Conference (September 12, 2019)
  • “Medical-Assisted Treatment in Opioid Addiction Setting,” American Pharmacists Association Annual Meeting (APhA2019) (March 23, 2019)
  • “Controlled Substances 101: Introduction to the Fundamentals,” American Conference Institute’s Summit on Controlled Substances (February 4, 2019)
  • “Demystifying Buprenorphine Opioid Addiction Treatment,” American Society for Pharmacy Law Annual Conference (November 2, 2018)
  • “Prescription Audits: When the DEA or AG Come Knocking,” Strafford Live CLE Webinar, Co-presenter (August 17, 2017)
  • “Addressing the Bouncing Ball of Prescription Drug Abuse: What have we Learned?”, Marion General Hospital, Marion, Illinois (May 18, 2016)
  • “Cracking the Code: Pharmaceutical & Controlled Substance Compliance for Remote Healthcare,” Webinar (March 31, 2016)
  • “Law Enforcement Responses to Fraud Rings, Burglaries and Robberies,” National Rx Drug Abuse Summit, Co-presenter (April 7, 2015)
  • “Representing Clients Targeted by Law Enforcement for a Voluntary Interview,” Muslim Advocates Webinar (June 3, 2014)
  • “Drugs R Us’: Navigating the Perilous Road Between Patient Needs and Government Scrutiny Involving Controlled Substances,” Oregon Health Care Association Annual Conference (September 16, 2013)
  • “Impact of Guidelines in Federal Healthcare Fraud Cases,” National Federal Sentencing Guidelines Conference (May 23, 2013)
  • “2013 Regulatory Enforcement Update,” Washington State Pharmacy Association’s Annual New Drugs New Laws Conference (February 10, 2013, April 21, 2013)
  • “2012 Regulatory Enforcement Update,” American Society for Pharmacy Law Annual Conference (November 16, 2012)
  • “Protect Your DEA Registration And Your Revenue’s Practice,” DecisionHealth Webinar, Host (January 26, 2012)
  • “Navigating the Difficult Road of Effective Pain Management: Understanding the New Opioid Rules,” Evergreen Hospital Medical Center Continuing Medical Education (December 16, 2011)
  • “DEA Decisions: Making Sense of Dissonant Decisions When Representing Pharmacists, “ American Society for Pharmacy Law Annual Conference (November 18, 2011)
  • “Avoiding Responding to Government Investigations of Medical Providers Who Prescribe Controlled Substances,” Washington State Society of Healthcare Attorneys’ Winter Quarterly Presentation (March 1, 2011)
  • “Defending a Financial Fraud Case and Getting a Good Result,” Northwest Fraud Investigators Association Conference (November 5, 2010)
  • “Responding to Audits and Investigations of One’s Medical Practice,” Washington Society of Addiction Medicine Conference (March 4, 2010)
  • Executive Committee, Board of Directors, Holocaust Center for Humanity, a nonprofit educational organization dedicated to promoting ideals of tolerance, and preventing hate, bigotry and genocide (2011-Present)
  • University of Chicago, Leaders in Philanthropy (2019)
  • Communications Committee, American Society for Pharmacy Law (2016-Present)
  • Board Member, The Valley School, a nonprofit primary school in Seattle, WA (2011-2017)
  • Mentor, Leadership Council on Legal Diversity Success in UW Law School Mentoring Program (2015)
  • Member, American Pharmacists Association (APhA) (2018-2019)
  • Member, Washington State Pharmacy Association (2012-Present)
  • Member, National Association of Specialty Pharmacy (2016-Present)
  • Member, American Society for Pharmacy Law (2011-Present)
  • Academic Peer Reviewer, California Pharmacist (2017)
  • Member, Washington State Attorney General’s Prescription Drug Advisory Group (2010-2012)
  • Member, National Association of Criminal Defense Lawyers (NACDL) (2010-Present)
  • Member, Washington Association of Criminal Defense Lawyers, (WACDL) (2010-Present)
  • Faculty, Trial Advocacy, University of Washington School of Law (1994-2005)
  • J.D., Harvard Law School
    • Massachusetts Public Defenders (1983)
    • Harvard Defenders (1980-1982)
  • B.A., with highest distinction, University of Virginia
  • Law Clerk to the Honorable Martin L.C. Feldman, U.S. District Judge, ED, Louisiana
  • Washington State Bar
  • District of Columbia Bar

701 Fifth Avenue, Suite 3300
Seattle, Washington 98104

206-224-8009 Direct
206-682-7100 Fax

Ronald J. Friedman

Rated by Super Lawyers

loading …



We welcome your interest in Karr Tuttle Campbell. However, we cannot represent you nor can we treat information as confidential until we know that doing so will not create a conflict of interest. Accordingly, please DO NOT send information about any matter unless you are an existing client AND one of our attorneys has explicitly affirmed that we represent you as a client in the matter to which your communication would pertain. Providing information via the “Contact Us” form on this website or otherwise will not create an attorney-client relationship in the absence of an express agreement by the Firm to create such a relationship, and will not prevent the Firm from representing someone else in connection with the matter in question or a related matter.